Evaluation of technologies approved for supplemental payments in the United States

Timothy J Judson; Sanket S Dhruva; Rita F Redberg

doi:10.1136/bmj.l2190

Evaluation of technologies approved for supplemental payments in the United States

BMJ. 2019 Jun 17:365:l2190. doi: 10.1136/bmj.l2190.

Authors

Timothy J Judson¹, Sanket S Dhruva^{1

2}, Rita F Redberg^{3

4}

Affiliations

¹ Department of Medicine, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94143, USA.
² San Francisco VA Medical Center, Section of Cardiology, San Francisco, CA 94121, USA.
³ Department of Medicine, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94143, USA rita.redberg@ucsf.edu.
⁴ Division of Cardiology, University of California, San Francisco, USA.

Abstract

Supplemental payment programmes can increase access to new technologies, but Timothy Judson and colleagues find that some payments are made without clear evidence of safety and effectiveness

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

Centers for Medicare and Medicaid Services, U.S. / economics*
Centers for Medicare and Medicaid Services, U.S. / legislation & jurisprudence
Health Expenditures*
Humans
Insurance Coverage / economics*
Medicare / economics*
Quality Assurance, Health Care
Social Security / economics*
Technology Assessment, Biomedical
United States

Grants and funding

UL1 TR000004/TR/NCATS NIH HHS/United States